Kevin Gordon

Kevin Gordon is a Kohlberg Operating Executive and serves on the board of directors of Worldwide Clinical Trials. He is currently a member of the board of directors at Progyny, Inc. (NSDQ: PGNY) and Q Holdco Limited. He previously served as Executive Vice President and Chief Operating Officer and Executive Vice President and Chief Financial Officer of Quintiles Transnational (now IQVIA), President and Chief Financial Officer of Liquidia Technologies, Inc. and Executive Vice President and Chief Financial Officer of Teleflex Incorporated. He served as a director at Veracyte, Inc. (NSDQ: VCYT), Sanisure, LLC and Cirtec Medical Corporation. He began his career at KPMG after earning a B.S in Accounting from the University of Connecticut.